TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Cryogenetics AS
Closing information (x1000 EUR)
| Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Turnover |
2,504
|
2,247
|
3,092 |
| Financial expenses |
82
|
60
|
243 |
| Earnings before taxes |
95
|
-169
|
-191 |
| Total assets |
2,912
|
2,820
|
3,442 |
| Current assets |
1,480
|
1,478
|
1,930 |
| Current liabilities |
573
|
758
|
847 |
| Equity capital |
1,456
|
1,354
|
1,606 |
| - share capital |
449
|
441
|
450 |
| Employees (average) | 10 | ||
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Solvency |
50.0%
|
48.0%
|
46.7% |
| Turnover per employee | 309 | ||
| Profit as a percentage of turnover |
3.8%
|
-7.5%
|
-6.2% |
| Return on assets (ROA) |
6.1%
|
-3.9%
|
1.5% |
| Current ratio |
258.3%
|
195.0%
|
227.9% |
| Return on equity (ROE) |
6.5%
|
-12.5%
|
-11.9% |
| Change turnover |
220
|
-787
|
898 |
| Change turnover % |
10%
|
-26%
|
41% |
| Chg. No. of employees | -9 | ||
| Chg. No. of employees % | -47% |
Total value of public sale
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.